KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization Amortization Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Novartis Ag (NVS) Depreciation & Amortization (CF) (2018)

Novartis Ag's Depreciation & Amortization (CF) history spans 3 years, with the latest figure at $930.0 million for Q1 2018.

On a quarterly basis, Depreciation & Amortization (CF) changed N/A to $930.0 million in Q1 2018 year-over-year; TTM through Dec 2018 was $930.0 million, a N/A change, with the full-year FY2009 number at $2341.0, changed N/A from a year prior.
Depreciation & Amortization (CF) hit $930.0 million in Q1 2018 for Novartis Ag, up from $665.0 in the prior quarter.
Over the last five years, Depreciation & Amortization (CF) for NVS hit a ceiling of $930.0 million in Q1 2018 and a floor of $930.0 million in Q1 2018.